These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27634883)

  • 1. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
    Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
    Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulatory effect and mechanism of RNA binding motif protein 38 on the expression of progesterone receptor in human breast cancer ZR-75-1 cells].
    Lou PP; Li CL; Xia TS; Shi L; Wu J; Zhou XJ; Wang Y; Ding Q
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):425-9. PubMed ID: 27346399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
    Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
    BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.
    Yin T; Cho SJ; Chen X
    J Biol Chem; 2013 Aug; 288(33):23680-6. PubMed ID: 23836903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.
    Shi L; Xia TS; Wei XL; Zhou W; Xue J; Cheng L; Lou P; Li C; Wang Y; Wei JF; Ding Q
    Oncotarget; 2015 May; 6(14):12264-78. PubMed ID: 25881544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
    Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
    Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.
    Zheng L; Zhang Z; Zhang S; Guo Q; Zhang F; Gao L; Ni H; Guo X; Xiang C; Xi T
    Mol Pharm; 2018 Jun; 15(6):2123-2132. PubMed ID: 29733656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.
    Zhang J; Jun Cho S; Chen X
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9614-9. PubMed ID: 20457941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
    Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability.
    Cho SJ; Zhang J; Chen X
    Nucleic Acids Res; 2010 Apr; 38(7):2256-67. PubMed ID: 20064878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.
    Finlay-Schultz J; Gillen AE; Brechbuhl HM; Ivie JJ; Matthews SB; Jacobsen BM; Bentley DL; Kabos P; Sartorius CA
    Cancer Res; 2017 Sep; 77(18):4934-4946. PubMed ID: 28729413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.
    Balmer LA; Beveridge DJ; Jazayeri JA; Thomson AM; Walker CE; Leedman PJ
    Mol Cell Biol; 2001 Mar; 21(6):2070-84. PubMed ID: 11238942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
    Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
    Zhang M; Xu E; Zhang J; Chen X
    Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation.
    Cho SJ; Jung YS; Zhang J; Chen X
    J Biol Chem; 2012 Apr; 287(18):14535-44. PubMed ID: 22371495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
    Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
    Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.